Systemic lupus erythematosus (SLE ... severe side effects and force physicians to use various drugs with other mechanisms of action. Antimalarial drugs, such as hydroxychloroquine (Plaquenil ...

SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life.

Systemic lupus erythematosus (SLE ... NPSLE-like symptoms and olfactory impairment might be induced by autoimmune mechanisms that target specific areas of the brain, but this has not been explored.

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of adults with moderate-to-severe systemic lupus erythematosus (SLE). The drug’s ...

Neutropenia, a condition characterized by low neutrophil levels, is common in individuals with systemic lupus erythematosus (SLE) and can lead to severe infections ... Further research is needed to ...

A study found a potential causal link between rheumatoid arthritis and increased prostate cancer risk. Researchers used ...

Systemic lupus erythematosus commonly presents as a rash. The rashes are caused by inflammation from the immune system fighting the body. Systemic lupus erythematosus, more commonly known as lupus ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...

More information: Henry W. Chen et al, Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus, JAMA Dermatology (2024). DOI: 10.1001/jamadermatol.2024.4991 ...